Pasadena Private Wealth, LLC - CLOVIS ONCOLOGY INC ownership

Back to all holdings Add to watchlist

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Pasadena Private Wealth, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$30,000
-33.3%
25,0000.0%0.01%
-26.7%
Q2 2022$45,000
-11.8%
25,0000.0%0.02%
-11.8%
Q1 2022$51,000
-25.0%
25,0000.0%0.02%
-22.7%
Q4 2021$68,000–25,000–0.02%–
 Download
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders